// App-Quantinova.ai

112 : "Disease Severity and Glucocorticoids Reduction in Systemic Lupus Erythematosus (SLE) Patients Receiving Belimumab in Clinical Practice Settings: Results from OBSErve Study in Canada"

Researchers

Presenter

  • Amyn Sayani

Principal Investigators

  • Sandra Iczkovitz

Medical Centers

  • Univ of Toronto, Toronto, Canada

Locations

  • Canada

Companies

  • GlaxoSmithKline plc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Glucocorticoid

  • Belimumab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved